3 transcripts
ITCI
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
.
I'd also like to give a quick update on our earlier-stage programs. We're exploring ITI-333 to treat opioid use disorder and pain. Our multiple semi
ITCI
Earnings call transcript
NASDAQ
2023 Q4
22 Feb 24
development programs include ITI for opioid use disorder in pain for which a multiple ascending dose study and a positron emission tomography study
ITCI
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
of different doses in healthy volunteers.
Lastly, we also have ongoing studies of ITI-333 for the treatment of opioid use disorder and pain. We have
- Prev
- 1
- Next